Melbourne researchers have uncovered genes responsible for the way the body fights infection at the point of ‘invasion’ – whether it’s the skin, liver, lungs or the gut.
Research led by Dr Axel Kallies and Dr Klaas van Gisbergen at the Walter and Eliza Hall Institute of Medical Research, and Dr Laura Mackay from the University of Melbourne at the Peter Doherty Institute for Infection and Immunity has identified the genes Hobit and Blimp1 and found that they control a universal molecular program responsible for placing immune cells at the ‘front lines’ of the body to fight infection and cancer.
The presence of these organ-residing cells, which differ strikingly from their counterparts circulating in the blood stream, is key to local protection against viruses and bacteria.
Walter and Eliza Hall Institute’s Dr Kallies said the human body was fighting disease-causing pathogens every minute of its life. Dr Kallies said identifying how immune cells remain in the part of the body where they are needed most was critical to developing better ways to protect us from infections such as malaria or HIV.
“Discovering these ‘local heroes’ and knowing how the localised immune response is established allows us to find ways to ensure the required cells are positioned where they are needed most,” Dr Kallies said.
“This research will help us understand how immune cells adapt, survive and respond within the organs they protect. This is critical to rid the body of pathogens even before they are established and may also have implications for understanding how the spread of cancer could be prevented.”
The Doherty Institute’s Dr Laura Mackay, who is also an associate investigator with the Australian Research Council Centre of Excellence in Advanced Molecular Imaging, said the factors that control the ‘tissue-residency’ of immune cells – their ability to locally reside in different organs of the body – was previously unknown.
“These results have major implications for developing strategies to induce immune cells in tissues that protect against infectious diseases,” Dr Mackay said.
“It’s a crucial discovery for future vaccine strategies – Hobit and Blimp1 would be key to placing immune cells in the tissues, which we know are really important for protection.”
The Latest on: Localised immune response
via Google News
The Latest on: Localised immune response
- Recent advances in immune therapies for gastric canceron March 4, 2021 at 12:17 pm
Gastric cancer (GC) is an aggressive malignancy that is the third leading cause of cancer mortality worldwide. Localized GC can be cured with surgery, but most patients present with more advanced ...
- Moderna's jab can cause skin reactions 11 DAYS after vaccinationon March 4, 2021 at 7:25 am
Doctors have reported at least 12 incidents of patients in the US presenting with large, red patches of skin which can be raised, itchy or painful, in an the unusual reaction to the Moderna jab.
- Immunogenicity of prime-boost protein subunit vaccine strategies against SARS-CoV-2 in mice and macaqueson March 3, 2021 at 3:25 am
Current vaccine strategies for SARS-CoV-2 focus on eliciting neutralising antibodies to the spike protein (S), but differences in immunogenicity of full-length S versus receptor binding domain (RBD) ...
- Ask the Doctors: Lupus treatment often requires many medicationson March 2, 2021 at 10:00 pm
"There are several forms of the disease, but the most common is systemic lupus, which can affect the joints, skin and certain internal organs, including the heart and kidneys." ...
- BioInvent and Transgene has enrolled first patient in Phase I/IIa trial of novel oncolytic virus BT-001 in solid tumorson February 28, 2021 at 10:58 pm
BioInvent International AB ("BioInvent") (Nasdaq Stockholm: BINV), a biotech company focused on the discovery and development of novel and first-in-class immune-modulatory antibodies for cancer ...
- Liquid biopsy could guide therapy for colorectal canceron February 25, 2021 at 11:54 am
Liquid biopsies can gauge the effectiveness of therapy for colorectal cancer that has begun to spread beyond the original tumor, researchers report.
- Why Feeling Bad After Covid Vaccine Jab Could Be Good: QuickTakeon February 24, 2021 at 7:03 am
As Covid-19 vaccines are rolled out across the world, a growing band of recipients are complaining of being flattened by side effects, especially after a second dose. Recipients describe symptoms from ...
- Expect More Side Effects After Second COVID-19 Vaccine Doseon February 24, 2021 at 6:13 am
As more people complaining about experiencing "side effects" after receiving their second dose of the coronavirus vaccine, various health experts have confirmed that this is normal and should not be a ...
- Should I get the COVID vaccine? Side effects after second dose explainedon February 23, 2021 at 10:59 am
As the coronavirus vaccines continue to be distributed across the US, there have been anecdotal reports of people experiencing more side effects after the second dose, but experts say this is a ...
- Experts explain why 2nd COVID-19 vaccine dose may have more side effectson February 23, 2021 at 9:54 am
Heinrich called the reaction a "normal immune response." Side effects include localized reactions, like swelling, rash or soreness at the injection site, which have been reported in about 84% of ...
via Bing News